These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 7557245

  • 1. Gastric antisecretory activity of lansoprazole in different experimental models: comparison with omeprazole.
    Coruzzi G, Adami M, Bertaccini G.
    Gen Pharmacol; 1995 Sep; 26(5):1027-32. PubMed ID: 7557245
    [Abstract] [Full Text] [Related]

  • 2. Gastroprotective activity of the novel proton pump inhibitor lansoprazole in the rat.
    Morini G, Grandi D, Arcari ML, Bertaccini G.
    Gen Pharmacol; 1995 Sep; 26(5):1021-5. PubMed ID: 7557244
    [Abstract] [Full Text] [Related]

  • 3. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
    Uchiyama K, Wakatsuki D, Kakinoki B, Takeuchi Y, Araki T, Morinaka Y.
    J Pharm Pharmacol; 1999 Apr; 51(4):457-64. PubMed ID: 10385219
    [Abstract] [Full Text] [Related]

  • 4. Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.
    Nagaya H, Inatomi N, Satoh H.
    Jpn J Pharmacol; 1991 Apr; 55(4):425-36. PubMed ID: 1886288
    [Abstract] [Full Text] [Related]

  • 5. Initial potency of lansoprazole and omeprazole tablets on pentagastrin-stimulated gastric acid secretion-a placebo-controlled study in healthy volunteers.
    Müller P, Göksu MA, Fuchs W, Schlüter F, Simon B.
    Aliment Pharmacol Ther; 2000 Sep; 14(9):1225-9. PubMed ID: 10971240
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the effect of lansoprazole in suppressing acid secretion using 24-hour intragastric pH monitoring.
    Takeda H, Hokari K, Asaka M.
    J Clin Gastroenterol; 1995 Sep; 20 Suppl 1():S7-9. PubMed ID: 7673616
    [Abstract] [Full Text] [Related]

  • 7. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
    Makovec F, Revel L, Letari O, Mennuni L, Impicciatore M.
    Eur J Pharmacol; 1999 Mar 12; 369(1):81-90. PubMed ID: 10204685
    [Abstract] [Full Text] [Related]

  • 8. Antisecretory activity of omeprazole in the conscious gastric fistula cat: comparison with famotidine.
    Coruzzi G, Bertaccini G.
    Pharmacol Res; 1989 Mar 12; 21(5):499-506. PubMed ID: 2531863
    [Abstract] [Full Text] [Related]

  • 9. The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion.
    Blum RA, Shi H, Karol MD, Greski-Rose PA, Hunt RH.
    Clin Ther; 1997 Mar 12; 19(5):1013-23. PubMed ID: 9385488
    [Abstract] [Full Text] [Related]

  • 10. Effects of lansoprazole on ethanol-induced injury and PG synthetic activity in rat gastric mucosa.
    Fukuda T, Arakawa T, Shimizu Y, Ohtani K, Higuchi K, Kobayashi K.
    J Clin Gastroenterol; 1995 Mar 12; 20 Suppl 2():S5-7. PubMed ID: 7594340
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A study comparing the antisecretory effect of TAK-438, a novel potassium-competitive acid blocker, with lansoprazole in animals.
    Hori Y, Matsukawa J, Takeuchi T, Nishida H, Kajino M, Inatomi N.
    J Pharmacol Exp Ther; 2011 Jun 12; 337(3):797-804. PubMed ID: 21411494
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of different antisecretory drugs on gastric potential difference in the rat: comparison with sucralfate.
    Coruzzi G, Coppelli G, Frati P, Bertaccini G.
    Pharmacol Res; 1998 Dec 12; 38(6):469-73. PubMed ID: 9990656
    [Abstract] [Full Text] [Related]

  • 15. [Effects of intravenous lansoprazole on acute gastric mucosal lesions and acid secretion].
    Inatomi N, Murakami I, Asano S, Inada I, Satoh H.
    Nihon Yakurigaku Zasshi; 1996 Dec 12; 108(6):333-43. PubMed ID: 9017687
    [Abstract] [Full Text] [Related]

  • 16. NC-1300, a proton-pump inhibitor, requires gastric acid to exert cytoprotection in rat gastric mucosa.
    Arakawa T, Fukuda T, Higuchi K, Koike K, Satoh H, Kobayashi K.
    Jpn J Pharmacol; 1993 Apr 12; 61(4):299-302. PubMed ID: 8391606
    [Abstract] [Full Text] [Related]

  • 17. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
    Satoh H, Inatomi N, Nagaya H, Inada I, Nohara A, Nakamura N, Maki Y.
    J Pharmacol Exp Ther; 1989 Feb 12; 248(2):806-15. PubMed ID: 2537418
    [Abstract] [Full Text] [Related]

  • 18. Effects of lansoprazole on gastric ulcer healing and mucin content.
    Komuro Y, Ishii K, Miyake Y, Tanabe S, Oida M, Saigenji K.
    J Clin Gastroenterol; 1995 Feb 12; 20 Suppl 2():S47-51. PubMed ID: 7594339
    [Abstract] [Full Text] [Related]

  • 19. Specific proton pump inhibitors E3810 and lansoprazole affect the recovery process of gastric secretion in rats differently.
    Tomiyama Y, Morii M, Takeguchi N.
    Biochem Pharmacol; 1994 Nov 29; 48(11):2049-55. PubMed ID: 7802694
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.